Macular Degeneration In June 2025, a large study of older adults with Type 2 diabetes found those who took a GLP-1 drug had a "substantially higher risk" of developing a rare type of age-related macular degeneration an eye disease that causes blindness than people with diabetes who didn't take the medication
Worth noting, caffeine is definitely not the only stimulant in either of these drinks--or others on the market--so it's probable that the FDA investigation may lead to further ingredient probing
IGF 1 rises, supporting recovery and fat metabolism
electronic health records by Epic Research, involving over 3,500 trial participants, found no increased risk of mental health issues in patients without a history of major mental illness who used semaglutide for obesity or diabetes
BACH1 is involved in various physiological processes and pathogenesis related to inflammation, oxidative stress damage, autoimmunity disorders, and cancer angiogenesis, among others [219]
A place for viruses on the tree of life
